Advances in drug delivery systems for Osteoarthritis therapy: exosomes, microparticles, nanoparticles, and hydrogels.

Authors

Yu-Xin Chen, Fei Zhang, Ya Ding, Ming-Hui Zheng, Zhi-Ang Zhou, Lei Qiu, Yi-Xin Yu, Ying-Ying Gu, Qi-Rong Deng, Kun Guo, Feng Xu, Xiao-Bo Liao, Ling-Qing Yuan, Le-Le Liao

Published in

Discover nano. Volume 21. Issue 1. Sep 14, 2026. Epub Sep 14, 2026.

Abstract

Osteoarthritis is a debilitating chronic joint disorder characterized by cartilage degradation, inflammation, and pain. It significantly impacts the quality of life, particularly in elderly populations. Traditional treatment methods, such as local and systemic drug administration, are limited by poor drug retention, low therapeutic efficacy, and systemic side effects. Recent advancements in drug delivery systems have emerged as promising strategies to overcome these limitations, offering targeted and sustained therapeutic effects, including promoting chondrocyte proliferation and migration, reducing extracellular matrix degradation, and so on. This review highlights the progress in various innovative drug delivery systems, including exosomes, microparticles, nanoparticles, and hydrogels, which have shown promising results in preclinical studies. Exosomes, particularly those derived from mesenchymal stem cells, demonstrate significant potential in promoting cartilage repair, modulating inflammation, and facilitating cell communication. Microparticles composed of natural or synthetic polymers prolong intra-articular drug retention and provide controlled release. Stimuli-responsive nanoparticles, which react to pathological cues like reactive oxygen species, pH, and enzymes, allow precise drug release within the OA microenvironment. Hydrogels offer versatile platforms for sustained delivery and tissue scaffolding, with responsive systems adapting to joint conditions. Despite their promising preclinical results, challenges remain in standardization, manufacturing scalability, and long-term safety. The continued development and clinical translation of these advanced systems hold great potential to revolutionize osteoarthritis therapy by improving efficacy, reducing side effects, and promoting joint tissue regeneration.

PMID:
42734879
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.